Next Article in Journal
Giraffe Stature and Neck Elongation: Vigilance as an Evolutionary Mechanism
Next Article in Special Issue
Subjective Mood in Young Unmedicated Depressed Women under High and Low Sleep Pressure Conditions
Previous Article in Journal
Quantifying Mosaic Development: Towards an Evo-Devo Postmodern Synthesis of the Evolution of Development via Differentiation Trees of Embryos
Previous Article in Special Issue
Circadian Regulation of Synaptic Plasticity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Individual Differences in the Post-Illumination Pupil Response to Blue Light: Assessment without Mydriatics

by
Jessica Bruijel
1,†,
Wisse P. Van der Meijden
1,2,3,*,†,
Denise Bijlenga
4,
Farangis Dorani
4,
Joris E. Coppens
1,
Bart H. W. Te Lindert
1,
J. J. Sandra Kooij
4 and
Eus J. W. Van Someren
1,5
1
Department of Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam 1105 BA, The Netherlands
2
Sleep Disorders Center, CHU and FMTS, CNRS-UPR 3212, Institute of Cellular and Integrative Neurosciences, University of Strasbourg, Strasbourg 67084, France
3
Center for Chronobiology, Psychiatric Hospital of the University of Basel, Basel CH-4012, Switzerland
4
PsyQ Psycho-Medical Programs, Expertise Center Adult ADHD, The Hague 2593 HR, The Netherlands
5
Departments of Integrative Neurophysiology and Psychiatry GGZ InGeest, Center for Neurogenomics and Cognitive Research (CNCR), Neuroscience Campus Amsterdam, VU University and Medical Center, Amsterdam 1081 HV, The Netherlands
*
Author to whom correspondence should be addressed.
Biology 2016, 5(3), 34; https://doi.org/10.3390/biology5030034
Submission received: 31 May 2016 / Revised: 25 August 2016 / Accepted: 30 August 2016 / Published: 9 September 2016
(This article belongs to the Special Issue Circadian Rhythms from Bench to Bedside)

Abstract

:
Melanopsin-containing retinal ganglion cells play an important role in the non-image forming effects of light, through their direct projections on brain circuits involved in circadian rhythms, mood and alertness. Individual differences in the functionality of the melanopsin-signaling circuitry can be reliably quantified using the maximum post-illumination pupil response (PIPR) after blue light. Previous protocols for acquiring PIPR relied on the use of mydriatics to dilate the light-exposed eye. However, pharmacological pupil dilation is uncomfortable for the participants and requires ophthalmological expertise. Hence, we here investigated whether an individual’s maximum PIPR can be validly obtained in a protocol that does not use mydriatics but rather increases the intensity of the light stimulus. In 18 participants (5 males, mean age ± SD: 34.6 ± 13.6 years) we evaluated the PIPR after exposure to intensified blue light (550 µW/cm2) provided to an undilated dynamic pupil. The test-retest reliability of the primary PIPR outcome parameter was very high, both between day-to-day assessments (Intraclass Correlation Coefficient (ICC) = 0.85), as well as between winter and summer assessments (ICC = 0.83). Compared to the PIPR obtained with the use of mydriatics and 160 µW/cm2 blue light exposure, the method with intensified light without mydriatics showed almost zero bias according to Bland-Altman plots and had moderate to strong reliability (ICC = 0.67). In conclusion, for PIPR assessments, increasing the light intensity is a feasible and reliable alternative to pupil dilation to relieve the participant’s burden and to allow for performance outside the ophthalmological clinic.

1. Introduction

The suprachiasmatic nucleus (SCN) in the hypothalamus encompasses the endogenous biological clock, which drives physiological, endocrine, and behavioral rhythms with a periodicity of about 24 h [1]. The daily environmental light-dark cycle serves as the main synchronizer to entrain these so called circadian rhythms to an exact 24-h cycle in order to remain in phase with the 24-h period of a day on Earth [2]. Intrinsically photosensitive retinal ganglion cells (ipRGCs) play a key role in this circadian photoentrainment [3,4]. ipRGCs express the photopigment melanopsin which enables them to intrinsically decode ambient light levels [3,5]. Melanopsin is maximally responsive to short-wavelength (i.e., blue) light with peak sensitivity between 460–480 nm. In addition, ipRGCs receive extrinsic input from rods and cones [6,7]. Through direct connections between ipRGCs and the brain, the integrated intrinsic and extrinsic information on environmental light is transferred from the retina to downstream non-image forming brain regions, with the SCN as one of the main targets [8].
Besides circadian photoentrainment, ipRGCs are also involved in the regulation of mood [9], alertness [10], pineal melatonin production [11], and the pupillary light reflex (PLR) [6]. The contribution of ipRGCs to the PLR is mediated through direct projections onto the olivary pretectal nucleus (OPN; i.e., the brain region for pupil size control [12]). The involvement of ipRGCs in the PLR allows for a non-invasive method to measure functionality of the intrinsic melanopsin-based signaling pathway [13]. More specifically, the characteristic sustained contraction of the pupil after blue light can be almost entirely assigned to the melanopsin-driven delay in ipRGC repolarization after light offset [14,15]. This phenomenon, known as the post-illumination pupil response (PIPR) [8], can thus be used to estimate the functionality of the intrinsic melanopsin-signaling circuitry [14].
Accordingly, we have previously developed a reliable and robust method to assess individual differences in the maximum PIPR [16] and showed its relevance for circadian entrainment [17]. The assessment procedures include pharmacological pupil dilation in the illuminated eye [18], which is highly uncomfortable for the participants [19]. The mydriatics that are used for pupil dilation, like tropicamide, phenylephrine, and cyclopentolate, entail several possible side effects including a dry mouth, blurred vision, stinging, and sensitivity of the eyes to light [20]. In addition, dilation of the pupil may persist up until 24 h after administration causing prolonged reduced sight, which is often experienced as unpleasant and impedes tasks like driving and reading [21]. A more serious risk is that pharmacological pupil dilation may lead to closed-angle glaucoma [22]. Ophthalmological expertise is therefore indispensable for the use of mydriatics. This proficiency is usually present in eye research. However, given the myriad of ipRGC-driven downstream photoregulatory functions, PIPR assessments are also highly relevant for non-ophthalmic research on sleep [17,23,24], cognition [25], alertness [10,26], mood and emotion [27], where ophthalmologic expertise to safely apply pupil dilation may be insufficient. Taken together, to relieve the participant’s burden and to allow for a wide application of safe PIPR measurements, it would be highly desirable to have a protocol that does not rely on the use of mydriatics while preserving the high reliability and robustness of the assessments.
Previous studies have presented reliable PIPR measurements without pharmacological mydriasis [28,29]. The PIPR in these previous studies was only transient, however, while we here aimed to elicit a more melanopsin-specific maximum prolonged PIPR. Considering that the PIPR increases with increasing light intensity [30,31,32,33], the aim of the present study was to examine whether an individual’s maximum PIPR can be validly assessed without mydriatics by instead increasing the intensity of the light stimulus [14]. We, therefore, examined the within-subject between-day test-retest reliability of an alternative protocol without mydriatics with increased light intensity and compared this to the previously found very high reliability of the protocol with mydriatics [16]. In a previous different protocol to assess PIPR, outcome measures showed variability across seasons [34]. We, therefore, evaluated whether our protocol without mydriatics might result in a more stable trait-like biomarker, robust across seasons, by assessing the test-retest reliability across the winter and summer.

2. Materials and Methods

2.1. Participants

A total of 18 volunteers (5 males, mean age ± SD (range): 34.6 ± 13.6 (22–69) years) were enrolled. Volunteers were assessed at two different locations with different experimenters and the same equipment: the Netherlands Institute for Neuroscience in Amsterdam (12 participants, 5 males, mean age ± SD: 35.8 ± 15.5 years) and PsyQ Expertise Center Adult ADHD in The Hague (6 participants, 0 males, mean age ± SD: 32.3 ± 9.4 years). All participants were informed about the procedure, signed informed consent, and did not receive any incentive. None of the participants had a self-claimed history of ocular pathology and none reported to use any medication known to influence the PLR. According to Nagel anomaloscope tests, none of the participants had a color vision deficiency. The study was approved by the Medical Ethical Committee of the VU University Medical Center Amsterdam (protocol NL43319.029.13) and adhered to the tenets of the Declaration of Helsinki.

2.2. Pupillometry

The previously established pupillometry procedures have been described elsewhere [16]. In brief, the right eye was exposed to an illumination protocol, while the left eye was continuously recorded using a custom-made infrared pupillometry set-up. The surface of the light source was 16 × 10 cm and the distance between the illuminated eye and the light stimulus was 5 cm. The light exposure protocol consisted of the following five 5-min intervals: baseline dark, monochromatic red light (635 nm) to maximize the pupil response after blue light, dark [35], monochromatic blue light (465 nm), and post-blue dark (Figure 1). These longer stimulus durations allow for more specific assessment of the melanopsin-signaling pathway because of the low sensitivity and slow kinetics of ipRGCs [3,36]. Previous research showed that light adaption of ipRGCs was completed after 5 min of light exposure, probably saturating the ipRGCs response [37]. From the baseline and post-blue pupil diameter two PIPR outcome parameters were calculated, the (1) PIPR-mm and the (2) PIPR-% [38,39]. We previously showed that these PIPR measurements have very high within-subject test-retest reliability [16].
PIPR-mm = baseline pupil diameter − post-blue pupil diameter
PIPR-% = 100 * PIPR-mm/baseline pupil diameter
The previously established protocol to assess the PIPR involved a blue light stimulus with an irradiance level of 160 µW/cm2 (Table 1) and the pupil of the right eye was dilated with the use of mydriatics, tropicamide 0.5% (160My+). The duration and intensity of the blue light stimulus [37,40], in combination with the pharmacological pupil dilation in the illuminated eye [18], were expected to saturate the melanopsin-driven photoresponse, resulting in a maximum PIPR. In order to examine whether the application of mydriatics substantially adds to eliciting the maximum PIPR this saturating PIPR assessment condition was compared to the condition with the same blue stimulus of 160 µW/cm2 but with the pupil in its natural undilated state (160My−). In order to assess whether increasing the intensity of the light stimulus may compensate for the possible reduced PIPR in the absence of pharmacological mydriasis the previously used saturating PIPR assessment condition was also compared to the condition in which the light intensity was increased, 550 µW/cm2 during blue light and the illuminated pupil was kept in its natural undilated state (550My−). In view of comments from participants in a previous pilot study, reporting major discomfort during exposure to a stimulus of such intensity with tropicamide application, we refrained from assessing the PIPR after intensified blue light with pharmacological mydriasis. Light intensities were calibrated using a spectrometer (AvaSpec-3648-USB2, Avantes, Apeldoorn, The Netherlands). The light stimuli activate all photoreceptors, the effect on each photoreceptor during each light stimulus are shown in Table 1. The melanopic lux indicates the strength of the melanopsin photoresponse. The order of the three conditions was randomized with 1 to 7 days between measurements. Full recovery of tropicamide application generally takes place within 6 h. In some cases, however the effects may last up until 24 h after administration [21]. PIPR assessments within a participant were therefore separated by at least 24 h. All sessions were performed between 9:30 a.m. and 4:00 p.m. in the months February and March 2016. To avoid time-of-day effects [41], the timing of the assessments was consistent within participants. All participants were invited to return to the lab on two consecutive days in the months July and August 2016 in order to assess the test-retest reliability of the 550My− protocol. The summer assessments were performed at the same time of day as the winter assessments. In order to assess the long-term cross-seasonal test-retest reliability between the winter and summer season, the PIPR outcome parameters of the first summer sessions were compared to the winter assessments.

2.3. Statistical Analysis

For both PIPR-mm and PIPR-%, differences between 160My+ and 160My− and differences between 160My+ and 550My− were visually inspected using Bland-Altman plots [43]. To evaluate whether 160My+ and 160My− procedures yield similar PIPR results a two-way random effect single measurement intraclass correlation coefficient (ICC) for absolute agreement was calculated [44]. Additional ICC values were calculated to examine reliability in pupil diameter during the baseline and post-blue intervals between 160My+ and 160My−. To compare differences in PIPR outcome measures, baseline and post-blue pupil diameter between 160My+ and 550My− the same ICC analyses were performed as in the comparison between 160My+ and 160My−. Bland-Altman plots and ICC analyses of the same outcome parameters were also used to evaluate the day-to-day test-retest reliability of 550My− protocol and to examine the seasonal effects on this condition. Data processing and analyses were conducted in R (version 3.2.1, R Foundation for Statistical Computing, Vienna, Austria), using the software packages “ICC” [45], “MethComp” [46], and “cocron” [47].

3. Results

The values for baseline and post-blue pupil diameter, PIPR-mm and PIPR-%, are shown in Table 2. Retinal illuminance during blue light was estimated based on the mean pupil diameter during blue light to be 18850 Td in 160My+, 1545 Td in 160My−, and 4897 Td in 550My−. Bland-Altman bias indicated low agreement between 160My+ and 160My− for the PIPR-mm and PIPR-%. In addition, there was low reliability between the PIPR outcome parameters in these conditions, as indicated by the ICC (PIPR-mm: −0.12; PIPR-%: −0.27) (Table 2). Negative ICC estimates indicate within-subject variability exceeding between-subject variability, and thus a very poor ICC [44]. There was also a low agreement between 160My+ and 160My− for the post-blue pupil diameter (ICC = 0.03).
The Bland-Altman plots indicated almost zero bias between 160My+ and 550My− for PIPR-mm and PIPR-% (Figure 2) indicating high agreement. When comparing the condition 160My+ to the condition 550My−, the ICC values indicate a moderate to strong agreement for the PIPR outcome parameters (PIPR-mm: ICC = 0.67; PIPR-%: ICC = 0.58). The ICC of 0.77 indicated a strong agreement between these conditions for the post-blue pupil diameter, which was confirmed by an almost-zero Bland-Altman bias.
During baseline dark there was an almost perfect agreement between 160My+ and 160My− (ICC = 0.88) and also between 160My + and 550My− (ICC = 0.92). Bland-Altman biases also indicated this high similarity (Table 3).
Fifteen (5 males, mean age ± SD (range): 36.4 ± 14.3 (23–70) years) out of the 18 participants returned to the lab for two consecutive summer assessments, one day apart. Bland-Altman plots indicated almost zero bias between the outcome measures of the 550My− protocol for PIPR-mm and PIPR-% (Figure 3), indicating high agreement. The ICC values for the PIPR outcome parameters moreover indicated a very high day-to-day test-retest reliability (PIPR-mm: ICC = 0.85; PIPR-%: ICC = 0.87) (Table 4).
The Bland-Altman plots also indicated almost zero bias between 550My− winter and 550My− summer measurements for PIPR-mm and PIPR-% (Figure 4), indicating high agreement. Again, the ICC values indicated a very high reliability for the PIPR outcome parameters (PIPR-mm: ICC = 0.83; PIPR-%: ICC = 0.80) (Table 5).

4. Discussion

In order to allow for a wide application of assessing the functionality of the melanopsin-signaling circuitry, we here examined whether an individual’s maximum PIPR can be validly assessed without mydriatics by instead increasing the intensity of the light exposure. In our previously established paradigm, with mydriatics, the 5-min duration of the blue light stimulus was expected to saturate the ipRGCs [16,37,40], leading to a maximum PIPR. Shorter blue light stimuli durations of milliseconds to a few seconds, as used in previous studies, may propose less discomfort for the participant but only elicit a transient PIPR (i.e., the post-exposure pupil diameter returns to baseline already during the assessment) [28,29,30,32]. On the contrary, our use of high intensity light stimuli of longer duration, tailored to the slow photoresponse and low sensitivity of ipRGCs, allows for more specific targeting of melanopsin-signaling pathway. Furthermore, in a previous shorter protocol to assess the PIPR, outcome measures showed variability across seasons [34]. Our longer protocol may result in a more trait-like biomarker that is stable across the winter and summer.
The previously established blue light stimulus with an irradiance of 160 µW/cm2, evoked a reduced PIPR when the pupil was kept in its natural dynamic state compared to the condition with the use of mydriatics. This indicates that dilation of the pupil or intensifying the light is required to evoke a maximum PIPR.
The retinal illuminance during blue light was over four times higher for the previously established protocol with mydriatics compared to the condition with intensified blue light without mydriatics. In spite of this fourfold difference, the PIPR did not systematically differ between these conditions. This suggests that during both conditions the ipRGCs response was saturated and a maximum PIPR was generated, since there was no further increase in PIPR even though the blue-light retinal illuminance was higher in the previously established protocol.
The moderate to strong agreement between the previously established 160 µW/cm2 blue light with mydriatics protocol and the alternative protocol with intensified blue light with a natural pupil indicates that both approaches are valid for eliciting the maximum PIPR. However, there can be individual variation between the results obtained with these two approaches, indicating that they should not be used interchangeably.
The within-subject test-retest of the protocol with intensified blue light with a natural pupil showed a very high agreement for both PIPR-mm and PIPR-%, approaching the reliability of our formerly established protocol with 160 µW/cm2 blue light and mydriatics (PIPR-mm: ICC = 0.90; PIPR-%: ICC = 0.87). This indicates that although the pupil is dynamic and the amount of light reaching the retina has a larger variation in the protocol with intensified blue light without mydriatics, this does not seem to affect the reliability of this protocol, suggesting saturation of the response at a certain intensity.
Previous research showed that the post-illumination contraction amplitude following blue light was larger in summer compared to winter [34]. However, there was only a difference between summer and winter for photopically adapted eyes. Our protocol with intensified blue light and a natural pupil showed no effect of season on the PIPR outcome parameters. We showed a very high agreement between the winter and summer measurements. Our protocol did not include an adaption period and provided the light stimulus for a much longer duration (i.e., 5 min instead of 1 s). The high reliability of our protocol with intensified blue light and a natural pupil, between days and even between seasons, provides it as a sensitive and robust possible biomarker to study trait-like individual differences in ipRGCs functioning.
In patients with retinal diseases pharmacological pupil dilation may not be without risk since dilation can lead to a rise in intraocular pressure [22]. With ipRGCs affected in diverse optic nerve and retinal diseases such as glaucoma [38,48], age-related macular degeneration [49], retinitis pigmentosa [50], and diabetes [51], PIPR measurements without dilation may provide a useful diagnostic tool. Excluding pharmacological dilation of the pupil from PIPR assessments is not only beneficial for ophthalmic patients, but also for individuals without eye-related complaints. Since pharmacological pupil dilation may be uncomfortable for participants and can even be dangerous when driving [52]. With the current reliable PIPR assessment protocol a maximum PIPR can be evoked without pupil dilation making the protocol accessible for non-ophthalmic research fields, such as sleep [17,23,24], cognition [25], alertness [10,26], mood and emotion research [27]. In addition, considering the important role ipRGCs play in circadian rhythms through their direct projections to the SCN, our current protocol can be easily applied in chronobiological studies.
A limitation of the study is the unequal gender distribution, there were more females included than males, which may have confounded our PIPR results. Accordingly, some parameters of the PLR were shown to be mildly affected by gender [53]. Future studies should, therefore, use a larger sample with a more even gender distribution to examine the effects of gender. Furthermore, future studies should examine whether the proposed protocol without pupil dilation is applicable in patients suffering from eye diseases and whether it may be used for diagnosing abnormalities in the melanopsin-signaling circuitry.

5. Conclusions

The aim of the present study was to evaluate an accessible PIPR assessment protocol without mydriatics to relieve the participant’s burden and to allow for a wide application of safe PIPR measurements. This protocol was an adaption of an established reliable pupillometry paradigm, which was designed to evoke a maximum PIPR in order to estimate functionality of the intrinsic melanopsin-dependent circuitry [16]. In spite of its reliability, its reliance on mydriatics may impede widespread use of the protocol. We therefore omitted pharmacological pupil dilation and instead increased the intensity of the light stimuli. For most participants this adapted protocol, without mydriatics, showed reasonable agreement with the previous protocol, with mydriatics, in PIPR outcome measures and there was no bias between the two methods. In addition, the protocol without mydriatics showed very high test-retest reliability for the PIPR outcome parameters, both between consecutive days as well as across seasons. In conclusion, the method presented here can be used to reliably quantify trait-like individual biomarkers of the functionality of the intrinsic melanopsin-signaling circuitry.

Acknowledgments

This project has been funded with support from the NeuroTime Erasmus+: Erasmus Mundus programme of the European Commission. This publication/communication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein. This work was supported by Project NeuroSIPE 10738, of the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation.

Author Contributions

Wisse P. van der Meijden, Denise Bijlenga, Joris E. Coppens, Bart H. W. te Lindert, J. J. Sandra Kooij and Eus J. W. Van Someren conceived and designed the experiment; Jessica Bruijel, Wisse P. van der Meijden, Denis Bijlenga and Farangis Dorani performed the experiments; Jessica Bruijel and Wisse P. van der Meijden analyzed the data; Jessica Bruijel, Wisse P. van der Meijden, Denise Bijlenga, Eus J. W. Van Someren wrote the paper. All authors commented on the paper and approved the final version.

Conflicts of Interest

The authors declare no conflicts of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the result.

Abbreviations

The following abbreviations are used in this manuscript:
SCNSuprachiasmatic Nucleus
ipRGCsintrinsically photosensitive Retinal Ganglion Cells
PLRPupillary Light Reflex
OPNOlivary Pretectal Nucleus
PIPRPost-Illumination Pupil Response
ICCIntraclass Correlation Coefficient
160My+160 µW/cm2 blue light Mydriatic pupil dilation
160My−160 µW/cm2 blue light Natural undilated pupil
550My−550 µW/cm2 blue light Natural undilated pupil

References

  1. Klein, D.C.; Moore, R.Y.; Reppert, S.M. Suprachiasmatic Nucleus: The Mind’s Clock; Oxford University Press: New York, NY, USA, 1991. [Google Scholar]
  2. Takahashi, J.S.; DeCoursey, P.J.; Bauman, L.; Menaker, M. Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature 1984, 308, 186–188. [Google Scholar] [CrossRef] [PubMed]
  3. Berson, D.M.; Dunn, F.A.; Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295, 1070–1073. [Google Scholar] [CrossRef] [PubMed]
  4. Thapan, K.; Arendt, J.; Skene, D.J. An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol. 2001, 535, 261–267. [Google Scholar] [CrossRef] [PubMed]
  5. Brainard, G.C.; Hanifin, J.P.; Greeson, J.M.; Byrne, B.; Glickman, G.; Gerner, E.; Rollag, M.D. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J. Neurosci. 2001, 21, 6405–6412. [Google Scholar] [PubMed]
  6. Dacey, D.M.; Liao, H.W.; Peterson, B.B.; Robinson, F.R.; Smith, V.C.; Pokorny, J.; Yau, K.W.; Gamlin, P.D. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 2005, 433, 749–754. [Google Scholar] [CrossRef] [PubMed]
  7. Wong, K.Y.; Dunn, F.A.; Graham, D.M.; Berson, D.M. Synaptic influences on rat ganglion-cell photoreceptors. J. Physiol. 2007, 582, 279–296. [Google Scholar] [CrossRef] [PubMed]
  8. Hattar, S.; Liao, H.W.; Takao, M.; Berson, D.M.; Yau, K.W. Melanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity. Science 2002, 295, 1065–1070. [Google Scholar] [CrossRef] [PubMed]
  9. Roecklein, K.A.; Wong, P.M.; Miller, M.A.; Donofry, S.D.; Kamarck, M.L.; Brainard, G.C. Melanopsin, photosensitive ganglion cells, and seasonal affective disorder. Neurosci. Biobehav. Rev. 2013, 37, 229–239. [Google Scholar] [CrossRef] [PubMed]
  10. Lockley, S.W.; Evans, E.E.; Scheer, F.A.; Brainard, G.C.; Czeisler, C.A.; Aeschbach, D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006, 29, 161–168. [Google Scholar] [PubMed]
  11. Lewy, A.J.; Wehr, T.A.; Goodwin, F.K.; Newsome, D.A.; Markey, S.P. Light suppresses melatonin secretion in humans. Science 1980, 210, 1267–1269. [Google Scholar] [CrossRef] [PubMed]
  12. Trejo, L.J.; Cicerone, C.M. Cells in the pretectal olivary nucleus are in the pathway for the direct light reflex of the pupil in the rat. Brain Res. 1984, 300, 49–62. [Google Scholar] [CrossRef]
  13. Hattar, S.; Kumar, M.; Park, A.; Tong, P.; Tung, J.; Yau, K.W.; Berson, D.M. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J. Comp. Neurol. 2006, 497, 326–349. [Google Scholar] [CrossRef] [PubMed]
  14. Gamlin, P.D.; McDougal, D.H.; Pokorny, J.; Smith, V.C.; Yau, K.W.; Dacey, D.M. Human and macaque pupil responses driven by melanopsin-containing retinal ganglion cells. Vis. Res. 2007, 47, 946–954. [Google Scholar] [CrossRef] [PubMed]
  15. Markwell, E.L.; Feigl, B.; Zele, A.J. Intrinsically photosensitive melanopsin retinal ganglion cell contributions to the pupillary light reflex and circadian rhythm. Clin. Exp. Optom. J. Aust. Optom. Assoc. 2010, 93, 137–149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Van der Meijden, W.P.; Te Lindert, B.H.; Bijlenga, D.; Coppens, J.E.; Gomez-Herrero, G.; Bruijel, J.; Kooij, J.J.; Cajochen, C.; Bourgin, P.; Van Someren, E.J. Post-illumination pupil response after blue light: Reliability of optimized melanopsin-based phototransduction assessment. Exp. Eye Res. 2015, 139, 73–80. [Google Scholar] [CrossRef] [PubMed]
  17. Van der Meijden, W.P.; Van Someren, J.L.; Te Lindert, B.H.; Bruijel, J.; van Oosterhout, F.; Coppens, J.E.; Kalsbeek, A.; Cajochen, C.; Bourgin, P.; Van Someren, E.J. Individual differences in sleep timing relate to melanopsin-based phototransduction in healthy adolescents and young adults. Sleep 2016, 39, 1305–1310. [Google Scholar] [CrossRef] [PubMed]
  18. Nissen, C.; Sander, B.; Lund-Andersen, H. The effect of pupil size on stimulation of the melanopsin containing retinal ganglion cells, as evaluated by monochromatic pupillometry. Front. Neurol. 2011. [Google Scholar] [CrossRef] [PubMed]
  19. Liew, G.; Mitchell, P.; Wang, J.J.; Wong, T.Y. Fundoscopy: To dilate or not to dilate? BMJ 2006. [Google Scholar] [CrossRef] [PubMed]
  20. Elibol, O.; Alcelik, T.; Yuksel, N.; Caglar, Y. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants. Acta Ophthalmol. Scand. 1997, 75, 178–180. [Google Scholar] [CrossRef] [PubMed]
  21. Hofmeister, E.M.; Kaupp, S.E.; Schallhorn, S.C. Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients. J. Cataract Refract. Surg. 2005, 31, 694–700. [Google Scholar] [CrossRef] [PubMed]
  22. Mapstone, R. Provocative tests in closed-angle glaucoma. Br. J. Ophthalmol. 1976, 60, 115–119. [Google Scholar] [CrossRef] [PubMed]
  23. Altimus, C.M.; Guler, A.D.; Villa, K.L.; McNeill, D.S.; Legates, T.A.; Hattar, S. Rods-cones and melanopsin detect light and dark to modulate sleep independent of image formation. Proc. Natl. Acad. Sci. USA 2008, 105, 19998–20003. [Google Scholar] [CrossRef] [PubMed]
  24. Lupi, D.; Oster, H.; Thompson, S.; Foster, R.G. The acute light-induction of sleep is mediated by opn4-based photoreception. Nat. Neurosci. 2008, 11, 1068–1073. [Google Scholar] [CrossRef] [PubMed]
  25. Vandewalle, G.; Maquet, P.; Dijk, D.J. Light as a modulator of cognitive brain function. Trends Cogn. Sci. 2009, 13, 429–438. [Google Scholar] [CrossRef] [PubMed]
  26. Rahman, S.A.; Flynn-Evans, E.E.; Aeschbach, D.; Brainard, G.C.; Czeisler, C.A.; Lockley, S.W. Diurnal spectral sensitivity of the acute alerting effects of light. Sleep 2014, 37, 271–281. [Google Scholar] [CrossRef] [PubMed]
  27. LeGates, T.A.; Fernandez, D.C.; Hattar, S. Light as a central modulator of circadian rhythms, sleep and affect. Nat. Rev. Neurosci. 2014, 15, 443–454. [Google Scholar] [CrossRef] [PubMed]
  28. Herbst, K.; Sander, B.; Milea, D.; Lund-Andersen, H.; Kawasaki, A. Test-retest repeatability of the pupil light response to blue and red light stimuli in normal human eyes using a novel pupillometer. Front. Neurol. 2011. [Google Scholar] [CrossRef] [PubMed]
  29. Lei, S.; Goltz, H.C.; Chandrakumar, M.; Wong, A.M. Test-retest reliability of hemifield, central-field, and full-field chromatic pupillometry for assessing the function of melanopsin-containing retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2015, 56, 1267–1273. [Google Scholar] [CrossRef] [PubMed]
  30. Park, J.C.; Moura, A.L.; Raza, A.S.; Rhee, D.W.; Kardon, R.H.; Hood, D.C. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. Investig. Ophthalmol. Vis. Sci. 2011, 52, 6624–6635. [Google Scholar] [CrossRef] [PubMed]
  31. Lei, S.; Goltz, H.C.; Chandrakumar, M.; Wong, A.M. Full-field chromatic pupillometry for the assessment of the postillumination pupil response driven by melanopsin-containing retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2014, 55, 4496–4503. [Google Scholar] [CrossRef] [PubMed]
  32. Adhikari, P.; Zele, A.J.; Feigl, B. The post-illumination pupil response (pipr). Investig. Ophthalmol. Vis. Sci. 2015, 56, 3838–3849. [Google Scholar] [CrossRef] [PubMed]
  33. Park, J.C.; McAnany, J.J. Effect of stimulus size and luminance on the rod-, cone-, and melanopsin-mediated pupillary light reflex. J. Vis. 2015. [Google Scholar] [CrossRef] [PubMed]
  34. Munch, M.; Kourti, P.; Brouzas, D.; Kawasaki, A. Variation in the pupil light reflex between winter and summer seasons. Acta Ophthalmol. 2016, 94, e244–e246. [Google Scholar] [CrossRef] [PubMed]
  35. Mure, L.S.; Cornut, P.L.; Rieux, C.; Drouyer, E.; Denis, P.; Gronfier, C.; Cooper, H.M. Melanopsin bistability: A fly’s eye technology in the human retina. PLoS ONE 2009, 4, e5991. [Google Scholar] [CrossRef] [PubMed]
  36. Do, M.T.; Kang, S.H.; Xue, T.; Zhong, H.; Liao, H.W.; Bergles, D.E.; Yau, K.W. Photon capture and signalling by melanopsin retinal ganglion cells. Nature 2009, 457, 281–287. [Google Scholar] [CrossRef] [PubMed]
  37. Wong, K.Y.; Dunn, F.A.; Berson, D.M. Photoreceptor adaptation in intrinsically photosensitive retinal ganglion cells. Neuron 2005, 48, 1001–1010. [Google Scholar] [CrossRef] [PubMed]
  38. Kankipati, L.; Girkin, C.A.; Gamlin, P.D. The post-illumination pupil response is reduced in glaucoma patients. Investig. Ophthalmol. Vis. Sci. 2011, 52, 2287–2292. [Google Scholar] [CrossRef] [PubMed]
  39. Roecklein, K.; Wong, P.; Ernecoff, N.; Miller, M.; Donofry, S.; Kamarck, M.; Wood-Vasey, W.M.; Franzen, P. The post illumination pupil response is reduced in seasonal affective disorder. Psychiatry Res. 2013, 210, 150–158. [Google Scholar] [CrossRef] [PubMed]
  40. Nelson, D.E.; Takahashi, J.S. Sensitivity and integration in a visual pathway for circadian entrainment in the hamster (mesocricetus auratus). J. Physiol. 1991, 439, 115–145. [Google Scholar] [CrossRef] [PubMed]
  41. Zele, A.J.; Feigl, B.; Smith, S.S.; Markwell, E.L. The circadian response of intrinsically photosensitive retinal ganglion cells. PLoS ONE 2011, 6, e17860. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Lucas, R.J.; Peirson, S.N.; Berson, D.M.; Brown, T.M.; Cooper, H.M.; Czeisler, C.A.; Figueiro, M.G.; Gamlin, P.D.; Lockley, S.W.; O’Hagan, J.B.; et al. Measuring and using light in the melanopsin age. Trends Neurosci. 2014, 37, 1–9. [Google Scholar] [CrossRef] [PubMed]
  43. Bland, J.M.; Altman, D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1, 307–310. [Google Scholar] [CrossRef]
  44. Shrout, P.E.; Fleiss, J.L. Intraclass correlations: Uses in assessing rater reliability. Psychol. Bull. 1979, 86, 420–428. [Google Scholar] [CrossRef] [PubMed]
  45. Wolak, M.E.; Fairbairn, D.J.; Paulsen, Y.R. Guidelines for estimating repeatability. Methods Ecol. Evol. 2012, 3, 129–137. [Google Scholar] [CrossRef]
  46. Carstensen, B.; Gurrin, L.; Ekstrom, C.; Figurski, M. Methcomp: Functions for Analysis of Agreement in Method Comparison Studies, version 1.22.2; R package, 2015.
  47. Diedenhofen, B. Cocron: Statistical Comparisons of Two or More Alpha Coefficients, version 1.0-0; R package, 2013.
  48. Feigl, B.; Mattes, D.; Thomas, R.; Zele, A.J. Intrinsically photosensitive (melanopsin) retinal ganglion cell function in glaucoma. Investig. Ophthalmol. Vis. Sci. 2011, 52, 4362–4367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Maynard, M.L.; Zele, A.J.; Feigl, B. Melanopsin-mediated post-illumination pupil response in early age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2015, 56, 6906–6913. [Google Scholar] [CrossRef] [PubMed]
  50. Kardon, R.; Anderson, S.C.; Damarjian, T.G.; Grace, E.M.; Stone, E.; Kawasaki, A. Chromatic pupillometry in patients with retinitis pigmentosa. Ophthalmology 2011, 118, 376–381. [Google Scholar] [CrossRef] [PubMed]
  51. Feigl, B.; Zele, A.J.; Fader, S.M.; Howes, A.N.; Hughes, C.E.; Jones, K.A.; Jones, R. The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol. 2012, 90, e230–e234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Potamitis, T.; Slade, S.V.; Fitt, A.W.; McLaughlin, J.; Mallen, E.; Auld, R.J.; Dunne, M.C.; Murray, P.I. The effect of pupil dilation with tropicamide on vision and driving simulator performance. Eye (Lond.) 2000, 14, 302–306. [Google Scholar] [CrossRef] [PubMed]
  53. Fan, X.; Hearne, L.; Lei, B.; Miles, J.H.; Takahashi, N.; Yao, G. Weak gender effects on transient pupillary light reflex. Auton. Neurosci. Basic Clin. 2009, 147, 9–13. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The change in pupil diameter of the left eye throughout the light exposure protocol in three different conditions. The traces represent the population mean pupil diameter, with the semi-transparent areas indicating the 95%-confidence interval, for each of the three conditions (red trace: the condition including 160 µW/cm2 blue light with the use of mydriatics (160My+), green trace: the condition including 160 µW/cm2 blue light with the pupil in its natural state (160My−), blue trace: the condition including 550 µW/cm2 blue light with the pupil in its natural state (550My−)). The bottom bar indicates the light exposure sequence, which was equal for all three condition (black = dark, red = monochromatic red light and blue = monochromatic blue light).
Figure 1. The change in pupil diameter of the left eye throughout the light exposure protocol in three different conditions. The traces represent the population mean pupil diameter, with the semi-transparent areas indicating the 95%-confidence interval, for each of the three conditions (red trace: the condition including 160 µW/cm2 blue light with the use of mydriatics (160My+), green trace: the condition including 160 µW/cm2 blue light with the pupil in its natural state (160My−), blue trace: the condition including 550 µW/cm2 blue light with the pupil in its natural state (550My−)). The bottom bar indicates the light exposure sequence, which was equal for all three condition (black = dark, red = monochromatic red light and blue = monochromatic blue light).
Biology 05 00034 g001
Figure 2. Bland-Altman plots for PIPR-mm (left) and PIPR-% (right) between 160 µW/cm2 blue light with mydriatics (160My+) and intensified blue light (550 µW/cm2) with natural pupil (550My−). Differences between the two conditions (i.e., 160My+ minus 550My−) are plotted against the mean of the two measurements. The dotted line represents the bias, i.e., the mean difference between all measurements of 160My+ and 550My−. The dashed lines are the 95% limits of agreement, 95% of the differences between the conditions lies between these lines. The smaller the limits of agreement, the better the agreement between the two measurements.
Figure 2. Bland-Altman plots for PIPR-mm (left) and PIPR-% (right) between 160 µW/cm2 blue light with mydriatics (160My+) and intensified blue light (550 µW/cm2) with natural pupil (550My−). Differences between the two conditions (i.e., 160My+ minus 550My−) are plotted against the mean of the two measurements. The dotted line represents the bias, i.e., the mean difference between all measurements of 160My+ and 550My−. The dashed lines are the 95% limits of agreement, 95% of the differences between the conditions lies between these lines. The smaller the limits of agreement, the better the agreement between the two measurements.
Biology 05 00034 g002
Figure 3. Bland-Altman plots for PIPR-mm (left) and PIPR-% (right) between the two consecutive summer assessments of the protocol with intensified blue light (550 µW/cm2) with a natural pupil (550My−). Differences between the two measurements (i.e., summer session 1 minus summer session 2) are plotted against the mean of the two measurements. The dotted line represents the bias, i.e., the mean difference between all measurements of the first session and all measurements of the second session. The dashed lines are the 95% limits of agreement: 95% of the differences between the conditions lies between these lines.
Figure 3. Bland-Altman plots for PIPR-mm (left) and PIPR-% (right) between the two consecutive summer assessments of the protocol with intensified blue light (550 µW/cm2) with a natural pupil (550My−). Differences between the two measurements (i.e., summer session 1 minus summer session 2) are plotted against the mean of the two measurements. The dotted line represents the bias, i.e., the mean difference between all measurements of the first session and all measurements of the second session. The dashed lines are the 95% limits of agreement: 95% of the differences between the conditions lies between these lines.
Biology 05 00034 g003
Figure 4. Bland-Altman plots for PIPR-mm (left) and PIPR-% (right) between the first summer sessions and winter assessments of the protocol with intensified blue light (550 µW/cm2) with a natural pupil (550My−). Differences between the two measurements (i.e., summer minus winter) are plotted against the mean of the two measurements. The dotted line represents the bias, i.e., the mean difference between all measurements of the summer and the winter.
Figure 4. Bland-Altman plots for PIPR-mm (left) and PIPR-% (right) between the first summer sessions and winter assessments of the protocol with intensified blue light (550 µW/cm2) with a natural pupil (550My−). Differences between the two measurements (i.e., summer minus winter) are plotted against the mean of the two measurements. The dotted line represents the bias, i.e., the mean difference between all measurements of the summer and the winter.
Biology 05 00034 g004
Table 1. Illuminance and luminance levels of the blue and red light during the previously established light conditions and the intensified light conditions. Since the light stimuli activate all photoreceptors, we estimated the photoinduced activation of each specific photoreceptor, expressed in α-opic lux, for each light stimulus.
Table 1. Illuminance and luminance levels of the blue and red light during the previously established light conditions and the intensified light conditions. Since the light stimuli activate all photoreceptors, we estimated the photoinduced activation of each specific photoreceptor, expressed in α-opic lux, for each light stimulus.
ParameterPreviously Used Blue LightIntensified Blue LightPreviously Used Red LightIntensified Red Light
Peak wavelength (nm) (full width half maximum)465 (20)465 (20)635 (20)635 (20)
Irradiance (µW/cm2)158.75548.96178.16473.34
Log photon flux (1/cm2/s)14.5715.1114.7515.18
Illuminance (lux (V(λ))120.91421.13327.03843.35
Luminance (cd/m2)37513003751000
α-opic lux
S coneNsc (λ)1131.923889.5412.2561.76
MelanopsinNz (λ)1060.863680.338.2136.84
RodNr (λ)751.942608.9112.7843.59
M coneNmc (λ)378.401315.53114.67297.14
L coneNlc (λ)198.81691.60419.581085.07
Details about the calculation of these values can be in found elsewhere [42].
Table 2. Outcome parameters of the pupil measurement from the three different conditions.
Table 2. Outcome parameters of the pupil measurement from the three different conditions.
Parameter160My+160My−550My−
Mean ± SDMinMaxMean ± SDMinMaxMean ± SDMinMax
Baseline (mm)5.91 ± 0.814.047.225.97 ± 0.794.087.255.96 ± 0.814.097.51
Post-Blue (mm)3.23 ± 0.532.204.354.33 ± 0.882.655.963.43 ± 0.592.364.71
PIPR-mm2.68 ± 0.571.443.831.65 ± 0.800.513.302.54 ± 0.661.413.51
PIPR-%45.23 ± 6.6129.8955.0827.40 ± 12.348.2255.4942.27 ± 8.3222.9954.03
The first 2 rows represent the mean pupil diameter during middle three minutes of the 5 min interval. 160My+, 160 µW/cm2 blue light with mydriatics; 160My−, 160 µW/cm2 blue light with natural pupil; 550My−, intensified blue light (550 µW/cm2 blue light) with natural pupil; PIPR, Post-Illumination Pupil Response.
Table 3. Reliability and agreement of the baseline and post-blue pupil diameter and the two PIPR outcome parameters when comparing the previously established protocol both to the condition with the same blue light intensity with a natural pupil as well as to a condition with intensified blue light and a natural pupil.
Table 3. Reliability and agreement of the baseline and post-blue pupil diameter and the two PIPR outcome parameters when comparing the previously established protocol both to the condition with the same blue light intensity with a natural pupil as well as to a condition with intensified blue light and a natural pupil.
Parameter160My+ − 160My−160My+ − 550My−
ICC (95% CI)Bland-Altman Bias (95% Limits of Agreement)ICC (95% CI)Bland-Altman Bias (95% Limits of Agreement)
Baseline0.88 (0.71–0.95)−0.06 (−0.84 to 0.73)0.92 (0.80–0.97)−0.05 (−0.72 to 0.62)
Post-Blue0.03 (−0.42–0.47)−1.10 (−2.40 to 0.91)0.77 (0.50–0.91)−0.20 (−0.87 to 0.48)
PIPR-mm−0.12 (−0.54–0.35)1.04 (−0.54 to 2.62)0.67 (0.32–0.86)0.15 (−0.84 to 1.14)
PIPR-%−0.27 (−0.64–0.21)17.83 (−5.36 to 41.01)0.58 (0.19–0.82)2.96 (−9.97 to 15.89)
PIPR, Post-Illumination Pupil Response; ICC, Intraclass Correlation Coefficient; 160My+, 160 µW/cm2 blue light with Mydriatics; 160My−, 160 µW/cm2 blue light with natural pupil; 550My−, intensified blue light (550 µW/cm2 blue light) with natural pupil; In Bland-Altman bias the 160My+ minus 160My− and 160My+ minus 550My−.
Table 4. Outcome parameters of the two consecutive summer assessments of the condition with intensified blue light with a natural pupil and test-retest reliability outcomes.
Table 4. Outcome parameters of the two consecutive summer assessments of the condition with intensified blue light with a natural pupil and test-retest reliability outcomes.
ParameterSummer Session 1 550My−Summer Session 2 550My−ICC (95% CI)Bland-Altman Bias (95% Limits of Agreement)
Mean ± SDMinMaxMean ± SDMinMax
PIPR-mm2.55 ± 0.671.303.362.52 ± 0.771.233.670.85 (0.62–0.95)0.03 (−0.79 to 0.85)
PIPR-%41.34 ± 9.3021.9750.3941.61 ± 9.8519.6952.280.87 (0.67–0.95)0.18 (−9.84 to 10.20)
PIPR, Post-Illumination Pupil Response; ICC, Intraclass Correlation Coefficient; 550My−, intensified blue light (550 µW/cm2 blue light) with a natural pupil.
Table 5. Outcome parameters from winter and summer measurements of the condition with intensified blue light with a natural pupil and reliability outcomes from summer and winter assessments.
Table 5. Outcome parameters from winter and summer measurements of the condition with intensified blue light with a natural pupil and reliability outcomes from summer and winter assessments.
ParameterWinter 550My−Summer 550My−ICC (95% CI)Bland-Altman bias (95% limits of agreement)
Mean ± SDMinMaxMean ± SDMinMax
PIPR-mm2.51 ± 0.701.413.512.55 ± 0.671.303.360.83 (0.57–0.94)0.05 (−0.78 to 0.89)
PIPR-%41.35 ± 8.8322.9954.0341.34 ± 9.3021.9750.390.80 (0.51–0.93)−0.01 (−11.82 to 11.80)
Summer 550My−, is the first summer assessments; PIPR, Post-Illumination Pupil Response; ICC, Intraclass Correlation Coefficient; 550My−, intensified blue light (550 µW/cm2 blue light) with a natural pupil. The Bland-Altman bias was defined as the summer minus the winter assessment.

Share and Cite

MDPI and ACS Style

Bruijel, J.; Van der Meijden, W.P.; Bijlenga, D.; Dorani, F.; Coppens, J.E.; Te Lindert, B.H.W.; Kooij, J.J.S.; Van Someren, E.J.W. Individual Differences in the Post-Illumination Pupil Response to Blue Light: Assessment without Mydriatics. Biology 2016, 5, 34. https://doi.org/10.3390/biology5030034

AMA Style

Bruijel J, Van der Meijden WP, Bijlenga D, Dorani F, Coppens JE, Te Lindert BHW, Kooij JJS, Van Someren EJW. Individual Differences in the Post-Illumination Pupil Response to Blue Light: Assessment without Mydriatics. Biology. 2016; 5(3):34. https://doi.org/10.3390/biology5030034

Chicago/Turabian Style

Bruijel, Jessica, Wisse P. Van der Meijden, Denise Bijlenga, Farangis Dorani, Joris E. Coppens, Bart H. W. Te Lindert, J. J. Sandra Kooij, and Eus J. W. Van Someren. 2016. "Individual Differences in the Post-Illumination Pupil Response to Blue Light: Assessment without Mydriatics" Biology 5, no. 3: 34. https://doi.org/10.3390/biology5030034

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop